Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038362 (
stomatitis
)
8,852
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Like other viruses, productive hepatitis C virus (HCV) infection depends on certain critical host factors. We have recently shown that an interaction between HCV nonstructural protein NS5A and a host protein,
TBC1D20
, is necessary for efficient HCV replication.
TBC1D20
contains a TBC (Tre-2, Bub2, and Cdc16) domain present in most known Rab GTPase-activating proteins (GAPs). The latter are master regulators of vesicular membrane transport, as they control the activity of membrane-associated Rab proteins. To better understand the role of the NS5A-
TBC1D20
interaction in the HCV life cycle, we used a biochemical screen to identify the
TBC1D20
Rab substrate.
TBC1D20
was found to be the first known GAP for Rab1, which is implicated in the regulation of anterograde traffic between the endoplasmic reticulum and the Golgi complex. Mutation of amino acids implicated in Rab GTPase activation by other TBC domain-containing GAPs abrogated the ability of
TBC1D20
to activate Rab1 GTPase. Overexpression of
TBC1D20
blocked the transport of exogenous vesicular
stomatitis
virus G protein from the endoplasmic reticulum, validating the involvement of
TBC1D20
in this pathway. Rab1 depletion significantly decreased HCV RNA levels, suggesting a role for Rab1 in HCV replication. These results highlight a novel mechanism by which viruses can hijack host cell machinery and suggest an attractive model whereby the NS5A-
TBC1D20
interaction may promote viral membrane-associated RNA replication.
...
PMID:TBC1D20 is a Rab1 GTPase-activating protein that mediates hepatitis C virus replication. 1790 Oct 50